GOLDMAN SACHS GROUP INC - CHECKMATE PHARMACEUTICALS IN ownership

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 37 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$145,00012,6000.00%
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders